Rebalix
Logo VanguardVanguard · sheet of 5 September 2026
ETF sheet · official issuer and register data

Vanguard U.S. Treasury 3-7 Year Bond UCITS ETF USD Acc

VITS · IE000VZ8BBU9 · USD · domicile Ireland
Bonds · Government USD · 3-7 years · North AmericaSFDR art. 6 (inferred)
Index tracked: Bloomberg U.S. 3-7 Year Treasury Index
TER
0.05%+ trans. 0.01%
Fund size
26 m EUR
Tracking difference
not computable
🇮🇹 tax rate
12.50%white list 99.97%
Replication
Physical (sampled)
Income
Accumulating
Duration
4.30 yrsmedium (3–7 years)
Launch 4 Nov 2025 · costs from the KID as of 2 Sept 2026 · 91 securities held · 10 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the Bloomberg US Treasury 3-7 Year Index (the “Index”). The Fund invests in a portfolio of fixed-rate, 3-7 Year US Dollardenominated US Treasury securities that so far as possible and practicable consists of a representative sample of the component securities of the Index. The Index is designed to reflect the universe of US Dollar-denominated, fixed rate, nominal debt issued by the US Treasury with…

Performance since series start (in euro) — base 100

4 Nov 20253 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
20261029699
High 102 (25 Jun 2026) · low 96 (28 Jan 2026) · last 99. Past performance is not indicative of future results.

Returns in euro

1 yearseries too young
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start−1.1%

Risk · 1 / 3 / 5 years

Volatility (ann.)
Max drawdown
Sharpe
Sortino
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · VITS · IE000VZ8BBU91
RebalixVITS · IE000VZ8BBU9 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: index series not published by the issuer

Fixed income — as declared by the issuer

Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 100.0%
Rating breakdown (% of fund)
AA100.0%Not rated0.0%
Maturity breakdown (% of fund)
< 1 year0.0%1–5 years64.3%5–10 years35.7%

Holdings

Portfolio as declared by the issuer · 31 Jul 2026 · 91 securities · top-10 weight = 19.5%
Countries (% of fund)
United States100.0%

Listing venues

ESMA register (FIRDS) and official exchange lists
VITS · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Euronext Amsterdam, Tradegate Exchange, Xetra (Deutsche Börse)
+ 7 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · fund-docs.vanguard.com/ie000vz8bbu9_priipskid_en.pdf
Factsheet · fund-docs.vanguard.com/U.S._Treasury_3-7_Year_Bond_UCITS_ETF_USD_Acc_E
Prospectus · fund-docs.vanguard.com/etf-prospectus-en.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE000VZ8BBU9
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · VITS · IE000VZ8BBU92